A recent preclinical study led by researchers at McGill University has identified two promising drug candidates—o-Vanillin and RG-7112—that could tackle chronic low back pain at its source by eliminating senescent cells, also known as “zombie… Scientists Discover 2 Drugs That Can End Lower Back Pain